Erxi Wu
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 14
- Oncology 39
- Cancer Cells and Metastasis 14
- Pancreatic and Hepatic Oncology Research 12
- Co-authors
- Qingyong Ma (45 shared papers)Fengfei Wang (27 shared papers)Qinhong Xu (24 shared papers)Wanxing Duan (25 shared papers)Xuqi Li (23 shared papers)Jiguang Ma (24 shared papers)Jason Haitao Huang (33 shared papers)Shuang Ying Zhou (17 shared papers)
- Journals
- Oncotarget (11 papers)PLoS ONE (8 papers)Current Molecular Medicine (7 papers)Current Medicinal Chemistry (6 papers)International Journal of Biological Sciences (5 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Erxi Wu
162 papers receiving 6.8k citations
Erxi Wu's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 1.1k
- Oncology 1.5k
- Geriatrics and Gerontology 191
- Toxicology 150
- Molecular Biology 2.8k
Countries citing papers authored by Erxi Wu
This map shows the geographic impact of Erxi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erxi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erxi Wu more than expected).
Fields of papers citing papers by Erxi Wu
This network shows the impact of papers produced by Erxi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erxi Wu. The network helps show where Erxi Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Erxi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 326 | |
| 2 | Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease Hit paper breakdown → | 2021 | 286 |
| 3 | 2011 | 195 | |
| 4 | 2011 | 168 | |
| 5 | 2012 | 167 | |
| 6 | 2013 | 140 | |
| 7 | 2013 | 138 | |
| 8 | 2014 | 138 | |
| 9 | 2015 | 136 | |
| 10 | 2008 | 128 | |
| 11 | 2011 | 124 | |
| 12 | 2017 | 120 | |
| 13 | 2013 | 119 | |
| 14 | 2009 | 117 | |
| 15 | 2012 | 108 | |
| 16 | 1998 | 102 | |
| 17 | 2009 | 99 | |
| 18 | 2016 | 97 | |
| 19 | 2008 | 97 | |
| 20 | 2011 | 94 |
About Erxi Wu
Erxi Wu is a scholar working on Cancer Research, Oncology, Molecular Biology, Neurology and Psychiatry and Mental health, having authored 164 papers that have together received 6.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (14 papers), Cancer Cells and Metastasis (14 papers), Cancer, Hypoxia, and Metabolism (14 papers), Pancreatic and Hepatic Oncology Research (12 papers), Cancer, Stress, Anesthesia, and Immune Response (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers), Glioma Diagnosis and Treatment (9 papers) and Hedgehog Signaling Pathway Studies (8 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.5k citations), Geriatrics and Gerontology (191 citations), Toxicology (150 citations) and Molecular Biology (2.8k citations). Erxi Wu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Qingyong Ma, Fengfei Wang, Qinhong Xu, Wanxing Duan, Xuqi Li, Jiguang Ma, Jason Haitao Huang, Shuang Ying Zhou, Jianjun Lei and Han Liu. Their work appears in journals such as Oncotarget, PLoS ONE, Current Molecular Medicine, Current Medicinal Chemistry and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.